In preclinical studies, treatment with the MEK inhibitor U0126 decreased proliferation in neuroblastoma cell lines with high constitutive total ERK, but not in those with less total ERK, indicated that this pathway plays a role in cell proliferation in some forms of neuroblastoma [67]. The gene discussed is MAP2K7; the disease is neuroblastoma.